GoodRx Holdings, Inc (GDRX) insider trading
Every open-market stock purchase and sale by GoodRx Holdings, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $95.1K over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Scott Wagner (Officer), $125K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $95.1K (1 sale). Last close $3.40 on Sep 17, 2026.
Recent GDRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | Thomas (TC) Chan (C-suite exec) | Sold (not open market) | $3.8K |
| Sep 15, 2026 | Justin Fengler (Officer) | Sold (not open market) | $3.6K |
| Sep 15, 2026 | Justin Fengler (Officer) | Sold (not open market) | $1.2K |
| Sep 15, 2026 | Justin Fengler (Officer) | Bought (not open market) | — |
| Sep 15, 2026 | Justin Fengler (Officer) | Bought (not open market) | — |
| Sep 15, 2026 | Thomas (TC) Chan (C-suite exec) | Bought (not open market) | — |
| Aug 15, 2026 | Justin Fengler (Officer) | Sold (not open market) | $41.8K |
| Aug 15, 2026 | Justin Fengler (Officer) | Sold (not open market) | $17.1K |
| Aug 15, 2026 | Justin Fengler (Officer) | Sold (not open market) | $10.5K |
| Aug 15, 2026 | Justin Fengler (Officer) | Sold (not open market) | $10.5K |
| Aug 15, 2026 | Thomas (TC) Chan (C-suite exec) | Sold (not open market) | $8.6K |
| Aug 15, 2026 | Thomas (TC) Chan (C-suite exec) | Sold (not open market) | $5K |
| Aug 15, 2026 | Thomas (TC) Chan (C-suite exec) | Sold (not open market) | $3.2K |
| Aug 15, 2026 | Thomas (TC) Chan (C-suite exec) | Sold (not open market) | $2.4K |
| Aug 15, 2026 | Thomas (TC) Chan (C-suite exec) | Bought (not open market) | — |
| Aug 15, 2026 | Thomas (TC) Chan (C-suite exec) | Bought (not open market) | — |
| Aug 15, 2026 | Justin Fengler (Officer) | Bought (not open market) | — |
| Aug 15, 2026 | Thomas (TC) Chan (C-suite exec) | Bought (not open market) | — |
| Aug 15, 2026 | Thomas (TC) Chan (C-suite exec) | Bought (not open market) | — |
| Aug 15, 2026 | Justin Fengler (Officer) | Bought (not open market) | — |
| Aug 15, 2026 | Justin Fengler (Officer) | Bought (not open market) | — |
| Aug 15, 2026 | Justin Fengler (Officer) | Bought (not open market) | — |
| Aug 10, 2026 | Justin Fengler (Officer) | Bought (not open market) | — |
| Jul 15, 2026 | Wendy Lynn Barnes (Officer) | Sold (not open market) | $151K |
| Jul 15, 2026 | Wendy Lynn Barnes (Officer) | Sold (not open market) | $145K |
Who's trading GDRX
- Justin Fengler, Officer: other filings, last Sep 15, 2026
- Thomas (TC) Chan, C-suite exec: other filings, last Sep 15, 2026
- Wendy Lynn Barnes, Officer: other filings, last Jul 15, 2026
- Christopher A McGinnis, Officer: other filings, last Jul 15, 2026
- Scott Wagner, Officer: other filings, last Jun 16, 2026
- Trevor Bezdek, Chair: other filings, last Jun 16, 2026
- Ronald E Bruehlman, Director: other filings, last Jun 16, 2026
- Douglas Joseph Hirsch, C-suite exec: other filings, last Jun 16, 2026
- Kelly J. Kennedy, Director: other filings, last Jun 16, 2026
- Agnes Rey-Giraud, Director: other filings, last Jun 16, 2026
- Romin Nabiey, C-suite exec: other filings, last Mar 8, 2026
- Spectrum Equity VII L.P., Insider: sold $95.1K (2 sales), last Oct 15, 2025
Get free alerts when an insider at GoodRx Holdings, Inc files a new trade →